MFS
PVLA

Mirabella Financial Services’s Palvella Therapeutics PVLA Stock Holding History

Mirabella Financial Services’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-160
Closed -$39K – 750
2022
Q1 		$39K Buy
+160
New +$42.1K ﹤0.01% 498

Other funds holding PVLA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mirabella Financial Services's PVLA Position: Q2 2022 in Review

Mirabella Financial Services sold out of Palvella Therapeutics (PVLA) in Q2 2022, closing a stake of 160 shares — an estimated $39K sold.

Mirabella Financial Services first reported a position in PVLA in Q1 2022 and held it in 1 quarter. The position peaked at $39K in Q1 2022. 68 funds tracked by Wall St. Rank hold PVLA as of Q2 2022.

  • Mirabella Financial Services reported no remaining Palvella Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Mirabella Financial Services sold 160 Palvella Therapeutics shares in Q2 2022, an estimated $39K.
  • Mirabella Financial Services first reported a position in Palvella Therapeutics in Q1 2022 and held it in 1 quarter.
  • Mirabella Financial Services's Palvella Therapeutics position peaked at $39K in Q1 2022.
  • 68 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2022.

Based on Mirabella Financial Services's 13F filing for Q2 2022, filed 12 Aug 2022.